TEDDM2P

Across TCGA pan-cancer cohorts, TEDDM2P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated TEDDM2P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher TEDDM2P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TEDDM2P expression acts as an unfavorable survival marker.

MESO, BRCA, and BLCA are the cancer types where TEDDM2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	IV	0.188	0.622	.021	63	view →
BRCA	DFS	Tertile	All	0.140	1.000	.001	39	view →
BLCA	OS	Tertile	All	0.185	0.456	.007	30	view →
GBM	OS	Tertile	All	0.005	0.416	<.001	18	view →
LUSC	DFS	Tertile	III,IV	0.079	0.751	.024	18	view →
ACC	OS	Tertile	All	0.186	0.640	.008	18	view →
LUAD	DFS	Tertile	IV	0.285	0.727	.009	18	view →
THYM	OS	Tertile	All	0.381	0.879	.003	12	view →
SARC	DFS	Tertile	All	0.181	0.605	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

TEDDM2P–MESO (OS)

Open the MESO breakdown →